Deceased donor kidneys allocated out of sequence by organ procurement organizations

Kristen L King1,2, S Ali Husain1,2, Adler Perotte3

  • 1Division of Nephrology, Department of Medicine, Vagelos College of Physicians & Surgeons, Columbia University, New York, New York, USA.

Insights

Organ procurement organizations (OPOs) are increasingly using allocation exceptions for deceased donor kidney transplants. This practice, concentrated in a few centers, may worsen transplant access disparities.

Area of Science:

  • Nephrology
  • Transplant Surgery
  • Public Health Policy

Background:

  • Deceased donor kidney allocation in the US relies on a ranked match-run system.
  • Organ procurement organizations (OPOs) can deviate from this system via allocation exceptions.

Purpose of the Study:

  • To analyze the frequency, characteristics, and recipients of OPO-initiated kidney allocation exceptions between 2015 and 2019.
  • To identify trends and potential disparities associated with these exceptions.

Main Methods:

  • Retrospective analysis of deceased donor kidney transplant match-run data from 2015-2019 in the US.
  • Identification and characterization of 1544 kidney transplants involving OPO-initiated allocation exceptions.

Main Results:

  • OPO-initiated exceptions increased significantly, with 3 OPOs accounting for 64% of cases.
  • Exception donors had less favorable characteristics, yet recipients received kidneys with shorter wait times.
  • Allocation exceptions were concentrated at larger transplant centers with higher offer acceptance rates.

Conclusions:

  • OPO-initiated kidney allocation exceptions are rising and becoming centralized at outlier centers.
  • This trend may lead to increased out-of-sequence allocations, potentially widening transplant access disparities.
  • Careful monitoring and policy evaluation are needed to ensure equitable organ distribution.

Related Concept Videos

Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
70
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
87
Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
562